This inventor holds 3 USPTO granted patents and 6 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Manuel Lopez, Jr.: Innovator in Anti-TNF Antibody Manufacturing
Introduction
Manuel Lopez, Jr. is a notable inventor based in Devon, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-TNF antibody compositions. With a total of 3 patents, his work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Lopez's latest patents include innovative manufacturing methods for producing anti-TNF antibody compositions. One of his patents focuses on methods of manufacture for producing a recombinant anti-TNF antibody that features a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37. Another patent presents methods for producing a recombinant anti-TNF antibody with a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37, along with compositions that include the recombinant anti-TNF antibody.
Career Highlights
Manuel Lopez, Jr. is currently employed at Janssen Biotech, Inc., where he continues to advance his research and development efforts. His work at this prominent biotechnology company allows him to collaborate with other experts in the field and contribute to groundbreaking innovations.
Collaborations
Some of his notable coworkers include Kristopher Barnthouse and Subinay Ganguly. Their collaborative efforts enhance the research environment and foster innovation within the company.
Conclusion
Manuel Lopez, Jr. is a distinguished inventor whose work in anti-TNF antibody manufacturing is paving the way for advancements in biotechnology. His contributions are essential for the development of new therapeutic solutions.